Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Dell'Acqua V, Surgo A, Arculeo S, Zerella MA, Bagnardi V, Frassoni S, Zampino MG, Ravenda PS, Rotundo MS, Kraja F, Kobiela J, Spychalski P, Fodor C, Gerardi MA, Cattani F, Bazani A, Petz W, Glynne-Jones R, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Dell'Acqua V, et al. Among authors: zerella ma. Int J Colorectal Dis. 2020 Apr;35(4):685-694. doi: 10.1007/s00384-020-03517-x. Epub 2020 Feb 8. Int J Colorectal Dis. 2020. PMID: 32036405
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.
Ricotti R, Seregni M, Ciardo D, Vigorito S, Rondi E, Piperno G, Ferrari A, Zerella MA, Arculeo S, Francia CM, Sibio D, Cattani F, De Marinis F, Spaggiari L, Orecchia R, Riboldi M, Baroni G, Jereczek-Fossa BA. Ricotti R, et al. Among authors: zerella ma. Med Phys. 2018 Apr;45(4):1360-1368. doi: 10.1002/mp.12804. Epub 2018 Mar 12. Med Phys. 2018. PMID: 29431863 Free article.
Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.
Dell'Acqua V, Kobiela J, Kraja F, Leonardi MC, Surgo A, Zerella MA, Arculeo S, Fodor C, Ricotti R, Zampino MG, Ravenda S, Spinoglio G, Biffi R, Bazani A, Luraschi R, Vigorito S, Spychalski P, Orecchia R, Glynne-Jones R, Jereczek-Fossa BA. Dell'Acqua V, et al. Among authors: zerella ma. Med Oncol. 2018 Mar 28;35(5):59. doi: 10.1007/s12032-018-1118-3. Med Oncol. 2018. PMID: 29594584
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R. Jereczek-Fossa BA, et al. Among authors: zerella ma. Med Oncol. 2018 Nov 27;36(1):9. doi: 10.1007/s12032-018-1233-1. Med Oncol. 2018. PMID: 30483899
Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesions.
Dell'Acqua V, Surgo A, Kraja F, Kobiela J, Zerella MA, Spychalski P, Gandini S, Francia CM, Ciardo D, Fodor C, Ferrari AM, Piperno G, Cattani F, Vigorito S, Pansini F, Petz W, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Dell'Acqua V, et al. Among authors: zerella ma. Clin Exp Metastasis. 2019 Aug;36(4):331-342. doi: 10.1007/s10585-019-09976-z. Epub 2019 Jun 4. Clin Exp Metastasis. 2019. PMID: 31165360
Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series.
Francia CM, Marvaso G, Piperno G, Gandini S, Ferrari A, Zerella MA, Arculeo S, Sibio D, Fodor C, Pepa M, Trivellato S, Rondi E, Vigorito S, Cattani F, Spaggiari L, De Marinis F, Orecchia R, Ciardo D, Jereczek-Fossa BA. Francia CM, et al. Among authors: zerella ma. Neoplasma. 2020 May;67(3):684-691. doi: 10.4149/neo_2020_190717N645. Epub 2020 Mar 18. Neoplasma. 2020. PMID: 32182088
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.
Dicuonzo S, Leonardi MC, Raimondi S, Corrao G, Bagnardi V, Gerardi MA, Morra A, Zerella MA, Zaffaroni M, Pansini F, Cattani F, Luraschi R, Fodor C, Veronesi P, Orecchia R, Rojas DP, Jereczek-Fossa BA. Dicuonzo S, et al. Among authors: zerella ma. Clin Transl Oncol. 2021 Jul;23(7):1415-1428. doi: 10.1007/s12094-020-02538-w. Epub 2021 Feb 3. Clin Transl Oncol. 2021. PMID: 33537865
The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors.
Alterio D, Augugliaro M, Tagliabue M, Bruschini R, Gandini S, Calabrese L, Belloni P, Preda L, Maffini FA, Marvaso G, Ferrari A, Volpe S, Zerella MA, Oneta O, Turturici I, Alessandro O, Ruju F, Ansarin M, Orecchia R, Jereczek-Fossa BA. Alterio D, et al. Among authors: zerella ma. Oral Dis. 2023 Jan;29(1):128-137. doi: 10.1111/odi.13885. Epub 2021 May 6. Oral Dis. 2023. PMID: 33893695
Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated.
Leonardi MC, Scognamiglio IR, Maisonneuve P, Dicuonzo S, Rojas DP, Zerella MA, Morra A, Gerardi MA, Zaffaroni M, De Scalzi A, Girardi A, Magnoni F, Montagna E, Fodor CI, Galimberti VE, Veronesi P, Orecchia R, Pacelli R, Jereczek-Fossa BA, Corso G. Leonardi MC, et al. Among authors: zerella ma. Breast Cancer Res Treat. 2021 Jul;188(2):511-524. doi: 10.1007/s10549-021-06227-2. Epub 2021 Apr 27. Breast Cancer Res Treat. 2021. PMID: 33905020
25 results